Tau Global Conference

About the Conference

Leading experts convened for the Tau Global Conference to collaborate and discuss key issues impacting the tau research community. This hybrid conference provided a forum for members of academia, industry, philanthropy and government to drive breakthroughs in tau research and treatment. We dove into cutting-edge work on biomarkers, drug development and emerging therapies — from cell biology to clinical translation.

This event brought together three major organizations dedicated to advancing research in this space: the Alzheimer's Association, Cure PSP and the Rainwater Charitable Foundation.

View the Program

Research Themes

All were invited to submit abstracts on the latest findings and ideas in tau research. Applicable themes included:

• Biomarkers — Neuroimaging
• Biomarkers — Non-Neuroimaging
• Clinical Manifestations
• Drug Development — Cell / In-Vitro / Animal Model
• Drug Development — Human
• Risk and Environmental Factors
• Genetics
• Molecular and Cell Biology
• Neuropathology
• Other

Scientific Program Committee

• Kristin Wildsmith, Chair
• Benjamin Wolozin, Chair
• Günter Höglinger
• Aimee Kao
• Cristian Lasagna Reeves
• Maura Malpetti
• Larisa Reyderman
• Chihiro Sato
• Tara Spires Jones
• Robby Weimer

Sponsors

Companies interested in sponsoring future conferences can contact Jennifer Lombardo, senior director of Corporate Initiatives, at jelombardo@alz.org.

Appropriate Conduct Policy

Tau Global Conference aims to provide a safe, equitable, and accessible experience for all conference participants.

Read the full Statement of Appropriate Conduct (PDF).

Contact

General questions: TauGlobal@alz.org
News media questions: AAICMedia@alz.org